Table of Contents
September 1, 2017; Volume 58,Issue Supplement 2
A
Altmann, Annette
- You have accessIdentification of Ligands and Translation to Clinical ApplicationsUwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John BabichJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791
B
Babich, John
- You have accessGlu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic RadiotracersKlaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn and John BabichJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 17S-26S; DOI: https://doi.org/10.2967/jnumed.116.186775
- You have accessIdentification of Ligands and Translation to Clinical ApplicationsUwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John BabichJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791
Bařinka, Cyril
- You have accessGlu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic RadiotracersKlaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn and John BabichJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 17S-26S; DOI: https://doi.org/10.2967/jnumed.116.186775
Benešová, Martina
- You have accessGlu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic RadiotracersKlaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn and John BabichJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 17S-26S; DOI: https://doi.org/10.2967/jnumed.116.186775
- You have accessTherapeutic Radiometals Beyond 177Lu and 90Y: Production and Application of Promising α-Particle, β−-Particle, and Auger Electron EmittersCristina Müller, Nicholas P. van der Meulen, Martina Benešová and Roger SchibliJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 91S-96S; DOI: https://doi.org/10.2967/jnumed.116.186825
Boas, F. Edward
- You have accessRadioembolization of Colorectal Liver Metastases: Indications, Technique, and OutcomesF. Edward Boas, Lisa Bodei and Constantinos T. SofocleousJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 104S-111S; DOI: https://doi.org/10.2967/jnumed.116.187229
Bodei, Lisa
- You have accessIn Memoriam: Dirk J. Kwekkeboom (1958–2017)Lisa BodeiJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 7A;
- You have accessRadioembolization of Colorectal Liver Metastases: Indications, Technique, and OutcomesF. Edward Boas, Lisa Bodei and Constantinos T. SofocleousJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 104S-111S; DOI: https://doi.org/10.2967/jnumed.116.187229
- You have accessSomatostatin Receptor 2–Targeting CompoundsDaan A. Smit Duijzentkunst, Dik J. Kwekkeboom and Lisa BodeiJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 54S-60S; DOI: https://doi.org/10.2967/jnumed.117.191015
Brouwers, Adrienne H.
- You have accessTheranostics Using Antibodies and Antibody-Related TherapeuticsKirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de VriesJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
C
Calais, Jeremie
- You have accessProstate-Specific Membrane Antigen Ligands for Imaging and TherapyMatthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. GieselJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
Cremonesi, Marta
- You have accessIndividualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?Uta Eberlein, Marta Cremonesi and Michael LassmannJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 97S-103S; DOI: https://doi.org/10.2967/jnumed.116.186841
D
de Groot, Derk Jan A.
- You have accessTheranostics Using Antibodies and Antibody-Related TherapeuticsKirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de VriesJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
de Vries, Elisabeth G.E.
- You have accessTheranostics Using Antibodies and Antibody-Related TherapeuticsKirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de VriesJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
E
Eberlein, Uta
- You have accessIndividualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?Uta Eberlein, Marta Cremonesi and Michael LassmannJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 97S-103S; DOI: https://doi.org/10.2967/jnumed.116.186841
Eiber, Matthias
- You have accessProstate-Specific Membrane Antigen Ligands for Imaging and TherapyMatthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. GieselJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
F
Fani, Melpomeni
- You have accessSomatostatin Receptor Antagonists for Imaging and TherapyMelpomeni Fani, Guillaume P. Nicolas and Damian WildJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 61S-66S; DOI: https://doi.org/10.2967/jnumed.116.186783
Fehrmann, Rudolf S.N.
- You have accessTheranostics Using Antibodies and Antibody-Related TherapeuticsKirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de VriesJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
Fendler, Wolfgang P.
- You have accessProstate-Specific Membrane Antigen Ligands for Imaging and TherapyMatthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. GieselJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
G
Giesel, Frederik L.
- You have accessProstate-Specific Membrane Antigen Ligands for Imaging and TherapyMatthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. GieselJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
Giesen, Danique
- You have accessTheranostics Using Antibodies and Antibody-Related TherapeuticsKirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de VriesJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
H
Haberkorn, Uwe
- You have accessGlu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic RadiotracersKlaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn and John BabichJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 17S-26S; DOI: https://doi.org/10.2967/jnumed.116.186775
- You have accessIdentification of Ligands and Translation to Clinical ApplicationsUwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John BabichJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791
Herold-Mende, Christel
- You have accessIdentification of Ligands and Translation to Clinical ApplicationsUwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John BabichJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791
Herrmann, Ken
- You have accessCXCR4 Ligands: The Next Big Hit?Annemiek M.E. Walenkamp, Constantin Lapa, Ken Herrmann and Hans-Jürgen WesterJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 77S-82S; DOI: https://doi.org/10.2967/jnumed.116.186874
- You have accessProstate-Specific Membrane Antigen Ligands for Imaging and TherapyMatthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. GieselJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
- You have accessTheranostic Concepts: More Than Just a Fashion Trend—Introduction and OverviewKen Herrmann, Steven M. Larson and Wolfgang A. WeberJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 1S-2S; DOI: https://doi.org/10.2967/jnumed.117.199570
Hetkamp, Philipp
- You have accessIodine Symporter Targeting with 124I/131I TheranosticsJames Nagarajah, Marcel Janssen, Philipp Hetkamp and Walter JentzenJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 34S-38S; DOI: https://doi.org/10.2967/jnumed.116.186866
Hofman, Michael S.
- You have accessProstate-Specific Membrane Antigen Ligands for Imaging and TherapyMatthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. GieselJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
J
Jalving, Mathilde
- You have accessTheranostics Using Antibodies and Antibody-Related TherapeuticsKirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de VriesJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
Janssen, Marcel
- You have accessIodine Symporter Targeting with 124I/131I TheranosticsJames Nagarajah, Marcel Janssen, Philipp Hetkamp and Walter JentzenJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 34S-38S; DOI: https://doi.org/10.2967/jnumed.116.186866
Jentzen, Walter
- You have accessIodine Symporter Targeting with 124I/131I TheranosticsJames Nagarajah, Marcel Janssen, Philipp Hetkamp and Walter JentzenJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 34S-38S; DOI: https://doi.org/10.2967/jnumed.116.186866
K
Kok, Iris C.
- You have accessTheranostics Using Antibodies and Antibody-Related TherapeuticsKirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de VriesJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
Kopka, Klaus
- You have accessGlu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic RadiotracersKlaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn and John BabichJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 17S-26S; DOI: https://doi.org/10.2967/jnumed.116.186775
- You have accessIdentification of Ligands and Translation to Clinical ApplicationsUwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John BabichJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791
Kratowchil, Clemens
- You have accessProstate-Specific Membrane Antigen Ligands for Imaging and TherapyMatthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. GieselJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
Krenning, Eric P.
- You have accessClinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P. Krenning by Rachel LevineRachel Levine and Eric P. KrenningJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 3S-9S; DOI: https://doi.org/10.2967/jnumed.116.186502
Kwekkeboom, Dik J.
- You have accessSomatostatin Receptor 2–Targeting CompoundsDaan A. Smit Duijzentkunst, Dik J. Kwekkeboom and Lisa BodeiJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 54S-60S; DOI: https://doi.org/10.2967/jnumed.117.191015
L
Lapa, Constantin
- You have accessCXCR4 Ligands: The Next Big Hit?Annemiek M.E. Walenkamp, Constantin Lapa, Ken Herrmann and Hans-Jürgen WesterJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 77S-82S; DOI: https://doi.org/10.2967/jnumed.116.186874
Larson, Steven M.
- You have accessTheranostic Concepts: More Than Just a Fashion Trend—Introduction and OverviewKen Herrmann, Steven M. Larson and Wolfgang A. WeberJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 1S-2S; DOI: https://doi.org/10.2967/jnumed.117.199570
Lassmann, Michael
- You have accessIndividualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?Uta Eberlein, Marta Cremonesi and Michael LassmannJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 97S-103S; DOI: https://doi.org/10.2967/jnumed.116.186841
Levine, Rachel
- You have accessClinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P. Krenning by Rachel LevineRachel Levine and Eric P. KrenningJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 3S-9S; DOI: https://doi.org/10.2967/jnumed.116.186502
Lub-de Hooge, Marjolijn N.
- You have accessTheranostics Using Antibodies and Antibody-Related TherapeuticsKirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de VriesJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
M
Maecke, Helmut R.
- You have accessApproaches to Multireceptor Targeting: Hybrid Radioligands, Radioligand Cocktails, and Sequential Radioligand ApplicationsJean Claude Reubi and Helmut R. MaeckeJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 10S-16S; DOI: https://doi.org/10.2967/jnumed.116.186882
Maurer, Tobias
- You have accessProstate-Specific Membrane Antigen Ligands for Imaging and TherapyMatthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. GieselJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
Mier, Walter
- You have accessIdentification of Ligands and Translation to Clinical ApplicationsUwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John BabichJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791
Modak, Shakeel
- You have accessNorepinephrine Transporter as a Target for Imaging and TherapyNeeta Pandit-Taskar and Shakeel ModakJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 39S-53S; DOI: https://doi.org/10.2967/jnumed.116.186833
Moek, Kirsten L.
- You have accessTheranostics Using Antibodies and Antibody-Related TherapeuticsKirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de VriesJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
Müller, Cristina
- You have accessTherapeutic Radiometals Beyond 177Lu and 90Y: Production and Application of Promising α-Particle, β−-Particle, and Auger Electron EmittersCristina Müller, Nicholas P. van der Meulen, Martina Benešová and Roger SchibliJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 91S-96S; DOI: https://doi.org/10.2967/jnumed.116.186825
N
Nagarajah, James
- You have accessIodine Symporter Targeting with 124I/131I TheranosticsJames Nagarajah, Marcel Janssen, Philipp Hetkamp and Walter JentzenJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 34S-38S; DOI: https://doi.org/10.2967/jnumed.116.186866
Nicolas, Guillaume P.
- You have accessSomatostatin Receptor Antagonists for Imaging and TherapyMelpomeni Fani, Guillaume P. Nicolas and Damian WildJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 61S-66S; DOI: https://doi.org/10.2967/jnumed.116.186783
P
Pandit-Taskar, Neeta
- You have accessNorepinephrine Transporter as a Target for Imaging and TherapyNeeta Pandit-Taskar and Shakeel ModakJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 39S-53S; DOI: https://doi.org/10.2967/jnumed.116.186833
R
Reubi, Jean Claude
- You have accessApproaches to Multireceptor Targeting: Hybrid Radioligands, Radioligand Cocktails, and Sequential Radioligand ApplicationsJean Claude Reubi and Helmut R. MaeckeJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 10S-16S; DOI: https://doi.org/10.2967/jnumed.116.186882
Rowe, Steven P.
- You have accessProstate-Specific Membrane Antigen Ligands for Imaging and TherapyMatthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. GieselJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
S
Schibli, Roger
- You have accessTherapeutic Radiometals Beyond 177Lu and 90Y: Production and Application of Promising α-Particle, β−-Particle, and Auger Electron EmittersCristina Müller, Nicholas P. van der Meulen, Martina Benešová and Roger SchibliJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 91S-96S; DOI: https://doi.org/10.2967/jnumed.116.186825
Schwarzenboeck, Sarah M.
- You have accessProstate-Specific Membrane Antigen Ligands for Imaging and TherapyMatthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. GieselJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767
Smit Duijzentkunst, Daan A.
- You have accessSomatostatin Receptor 2–Targeting CompoundsDaan A. Smit Duijzentkunst, Dik J. Kwekkeboom and Lisa BodeiJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 54S-60S; DOI: https://doi.org/10.2967/jnumed.117.191015
Sofocleous, Constantinos T.
- You have accessRadioembolization of Colorectal Liver Metastases: Indications, Technique, and OutcomesF. Edward Boas, Lisa Bodei and Constantinos T. SofocleousJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 104S-111S; DOI: https://doi.org/10.2967/jnumed.116.187229
V
van der Meulen, Nicholas P.
- You have accessTherapeutic Radiometals Beyond 177Lu and 90Y: Production and Application of Promising α-Particle, β−-Particle, and Auger Electron EmittersCristina Müller, Nicholas P. van der Meulen, Martina Benešová and Roger SchibliJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 91S-96S; DOI: https://doi.org/10.2967/jnumed.116.186825
W
Walenkamp, Annemiek M.E.
- You have accessCXCR4 Ligands: The Next Big Hit?Annemiek M.E. Walenkamp, Constantin Lapa, Ken Herrmann and Hans-Jürgen WesterJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 77S-82S; DOI: https://doi.org/10.2967/jnumed.116.186874
Weber, Wolfgang A.
- You have accessTheranostic Concepts: More Than Just a Fashion Trend—Introduction and OverviewKen Herrmann, Steven M. Larson and Wolfgang A. WeberJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 1S-2S; DOI: https://doi.org/10.2967/jnumed.117.199570
Wester, Hans-Jürgen
- You have accessCXCR4 Ligands: The Next Big Hit?Annemiek M.E. Walenkamp, Constantin Lapa, Ken Herrmann and Hans-Jürgen WesterJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 77S-82S; DOI: https://doi.org/10.2967/jnumed.116.186874
Wild, Damian
- You have accessSomatostatin Receptor Antagonists for Imaging and TherapyMelpomeni Fani, Guillaume P. Nicolas and Damian WildJournal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 61S-66S; DOI: https://doi.org/10.2967/jnumed.116.186783